BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...Stanford University and was CMO at Graybug Vision Inc. (NASDAQ:GRAY).Setback for Liquidia PAH therapyThe Liquidia Technologies Inc. subsidiary of Liquidia...
...GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant Sciences Ltd. Liquidia Technologies Inc. Gastrointestinal Ophthalmic Cardiovascular Irritable...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...iOnctura S.A. appointed Joanna Horobin as non-executive chair. She also serves on the boards of Liquidia Technologies Inc....
BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...Serafini-Lamanna to EVP, diagnostics from global VP and general manager of diagnostics. Particle engineering company Liquidia Technologies Inc....
...be based in the firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian Biopharmaceuticals Liquidia Technologies Inc. Amphista...
BioCentury | Apr 10, 2020
Product Development

April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge

...FDA to review Liquidia’s PAH therapy FDA accepted for review an NDA for LIQ861 from Liquidia Technologies Inc....
...Opdivo (Other) Yervoy (Brand), MDX-CTLA-4 (Compound #), MDX-010 (Compound #), BMS-734016 (Compound #), ipilimumab (Generic), Yervoy (Other) Liquidia Technologies Inc. Bridge...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...Phase III data 2H19 Lipocine Inc. (NASDAQ:LPCN) Tlando testosterone undecanoate Treat hypogonadism PDUFA date 11/9/19 Liquidia Technologies Inc....
BioCentury | Apr 16, 2019
Company News

Management tracks: Ginkgo Bioworks, KSQ, Milestone, Cerebral

...Frank Malinoski as SVP, clinical development and regulatory affairs. Malinoski's previous roles include CMO at Liquidia Technologies Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...Inc. (NASDAQ:LXRX) / Sanofi (Euronext:SAN; NASDAQ:SNY) Zynquista sotagliflozin Treat Type I diabetes EC action 2Q19 Liquidia Technologies Inc....
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...$399.8 $1,994.8 $911.6 -54% Union Korea Pharm. Co. Ltd. (KOSDAQ:080720) 7/26/18 $23.9 $91.4 $69.5 -24% Liquidia Technologies Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Ltd. (Tokyo:4151) / Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) Fotivda tivozanib Renal cell carcinoma Submit NDA Mid-2019 Liquidia Technologies Inc....
BioCentury | Jul 27, 2018
Financial News

Liquidia prices $50M IPO

...million shares at $11 in an IPO underwritten by Jefferies, Cowen, Needham and Wedbush PacGrow. Liquidia...
...the middle of its proposed range of $10-$12. The price valued Liquidia at $166.3 million. Liquidia...
...Xeraya Capital, the Bill & Melinda Gates Foundation and Morningside Ventures. Liquidia Technologies Inc. (NASDAQ:LQDA), Morrisville, N.C. Paul Bonanos LIQ861 Liquidia Technologies Inc....
Items per page:
1 - 10 of 41
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...Stanford University and was CMO at Graybug Vision Inc. (NASDAQ:GRAY).Setback for Liquidia PAH therapyThe Liquidia Technologies Inc. subsidiary of Liquidia...
...GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant Sciences Ltd. Liquidia Technologies Inc. Gastrointestinal Ophthalmic Cardiovascular Irritable...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...iOnctura S.A. appointed Joanna Horobin as non-executive chair. She also serves on the boards of Liquidia Technologies Inc....
BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...Serafini-Lamanna to EVP, diagnostics from global VP and general manager of diagnostics. Particle engineering company Liquidia Technologies Inc....
...be based in the firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian Biopharmaceuticals Liquidia Technologies Inc. Amphista...
BioCentury | Apr 10, 2020
Product Development

April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge

...FDA to review Liquidia’s PAH therapy FDA accepted for review an NDA for LIQ861 from Liquidia Technologies Inc....
...Opdivo (Other) Yervoy (Brand), MDX-CTLA-4 (Compound #), MDX-010 (Compound #), BMS-734016 (Compound #), ipilimumab (Generic), Yervoy (Other) Liquidia Technologies Inc. Bridge...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...Phase III data 2H19 Lipocine Inc. (NASDAQ:LPCN) Tlando testosterone undecanoate Treat hypogonadism PDUFA date 11/9/19 Liquidia Technologies Inc....
BioCentury | Apr 16, 2019
Company News

Management tracks: Ginkgo Bioworks, KSQ, Milestone, Cerebral

...Frank Malinoski as SVP, clinical development and regulatory affairs. Malinoski's previous roles include CMO at Liquidia Technologies Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...Inc. (NASDAQ:LXRX) / Sanofi (Euronext:SAN; NASDAQ:SNY) Zynquista sotagliflozin Treat Type I diabetes EC action 2Q19 Liquidia Technologies Inc....
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...$399.8 $1,994.8 $911.6 -54% Union Korea Pharm. Co. Ltd. (KOSDAQ:080720) 7/26/18 $23.9 $91.4 $69.5 -24% Liquidia Technologies Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...Ltd. (Tokyo:4151) / Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) Fotivda tivozanib Renal cell carcinoma Submit NDA Mid-2019 Liquidia Technologies Inc....
BioCentury | Jul 27, 2018
Financial News

Liquidia prices $50M IPO

...million shares at $11 in an IPO underwritten by Jefferies, Cowen, Needham and Wedbush PacGrow. Liquidia...
...the middle of its proposed range of $10-$12. The price valued Liquidia at $166.3 million. Liquidia...
...Xeraya Capital, the Bill & Melinda Gates Foundation and Morningside Ventures. Liquidia Technologies Inc. (NASDAQ:LQDA), Morrisville, N.C. Paul Bonanos LIQ861 Liquidia Technologies Inc....
Items per page:
1 - 10 of 41